Profiling and Bioinformatics Analyses of Differential Circular RNA Expression in Prostate Cancer Cells

References

• Jeck WR, Sorrentino JA, Wang K et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19(2), 141–157 (2013).
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441), 333–338 (2013).
   PubMed Web of Science ®Google Scholar
• Chen W, Schuman E. Circular RNAs in brain and other tissues: a functional enigma. Trends Neurosci. 39(9), 597–604 (2016).
   PubMed Web of Science ®Google Scholar
• Guo JU, Agarwal V, Guo H, Bartel DP. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 15(7), 409 (2014).
   PubMed Web of Science ®Google Scholar
• Lasda E, Parker R. Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance. PLoS ONE 11(2), e0148407; 1–11 (2016).
   PubMed Web of Science ®Google Scholar
• Legnini I, Di Timoteo G, Rossi F et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol. Cell 66(1), 22–37; e29 (2017).
   PubMed Web of Science ®Google Scholar
• Pamudurti NR, Bartok O, Jens M et al. Translation of circRNAs. Mol. Cell 66(1), 9–21; e27 (2017).
   PubMed Web of Science ®Google Scholar
• Xu H, Guo S, Li W, Yu P. The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci. Rep. 5, 12453 (2015).
   PubMed Web of Science ®Google Scholar
• Geng HH, Li R, Su YM et al. The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PLoS ONE 11(3), e0151753; 1–17 (2016).
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang X, Hu X et al. Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 ‘sponge’ in human cartilage degradation. Sci. Rep. 6, 22572 (2016).
   PubMed Web of Science ®Google Scholar
• Lukiw WJ. Circular RNA (circRNA) in Alzheimer’s disease (AD). Front. Genet. 4, 307 (2013).
   PubMedGoogle Scholar
• Xia W, Qiu M, Chen R et al. Circular RNA has_circ_0067934 is upregulated in esophageal squamous cell carcinoma and promoted proliferation. Sci. Rep. 6, 35576 (2016).
   PubMed Web of Science ®Google Scholar
• Han D, Li J, Wang H et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 66(4), 1151–1164 (2017).
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Zheng Q et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer. Cancer Lett. 388, 208–219 (2017).
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Lin YC, Gupta SK et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 77(9), 2339–2350 (2017).
   PubMed Web of Science ®Google Scholar
• Zhong Z, Lv M, Chen J. Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma. Sci. Rep. 6, 30919 (2016).
   PubMed Web of Science ®Google Scholar
• Ahmed I, Karedath T, Andrews SS et al. Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma. Oncotarget 7(24), 36366–36381 (2016).
   PubMedGoogle Scholar
• Zhu X, Wang X, Wei S et al. hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma. FEBS J. 284(14), 2170–2182 (2017).
   PubMed Web of Science ®Google Scholar
• Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 61(6), 1079–1092 (2012).
   PubMed Web of Science ®Google Scholar
• Ma G, Tang M, Wu Y, Xu X, Pan F, Xu R. LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer. Am. J. Transl. Res. 8(12), 5141–5150 (2016).
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14), 1754–1760 (2009).
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang J, Zhao F. CIRI: an efficient and unbiased algorithm for de novo circular RNA identification. Genome Biol. 16, 4 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan Y, Lei X et al. Circular RNA alterations are involved in resistance to avian leukosis virus subgroup-J-induced tumor formation in chickens. Oncotarget 8(21), 34961–34970 (2017).
   PubMedGoogle Scholar
• Su H, Lin F, Deng X et al. Profiling and bioinformatics analyses reveal differential circular RNA expression in radioresistant esophageal cancer cells. J. Transl. Med. 14(1), 225 (2016).
   PubMedGoogle Scholar
• Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell 159(1), 134–147 (2014).
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 44(6), 2846–2858 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang XO, Chen T et al. Circular intronic long noncoding RNAs. Mol. Cell 51(6), 792–806 (2013).
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti NR et al. circRNA biogenesis competes with pre-mRNA splicing. Mol. Cell 56(1), 55–66 (2014).
   PubMed Web of Science ®Google Scholar
• Peng X, Guo W, Liu T et al. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS ONE 6(5), e20341; 1–13 (2011).
   PubMed Web of Science ®Google Scholar
• Josson S, Chung LW, Gururajan M. microRNAs and prostate cancer. Adv. Exp. Med. Biol. 889, 105–118 (2015).
   PubMed Web of Science ®Google Scholar
• Qin W, Zhao B, Shi Y, Yao C, Jin L, Jin Y. BMPRII is a direct target of miR-21. Acta Biochim. Biophys. Sin. (Shanghai) 41(7), 618–623 (2009).
   PubMed Web of Science ®Google Scholar
• Shi XB, Xue L, Yang J et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl Acad. Sci. USA 104(50), 19983–19988 (2007).
   PubMed Web of Science ®Google Scholar
• Galardi S, Mercatelli N, Giorda E et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J. Biol. Chem. 282(32), 23716–23724 (2007).
   PubMed Web of Science ®Google Scholar
• Calin GA, Sevignani C, Dumitru CD et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101(9), 2999–3004 (2004).
   PubMed Web of Science ®Google Scholar
• Ostling P, Leivonen SK, Aakula A et al. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Cancer Res. 71(5), 1956–1967 (2011).
   PubMed Web of Science ®Google Scholar
• Shi XB, Xue L, Ma AH et al. Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene 32(35), 4130–4138 (2013).
   PubMed Web of Science ®Google Scholar
• Qu F, Cui X, Hong Y et al. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor. Mol. Cell Biochem 377(1–2), 121–130 (2013).
   PubMed Web of Science ®Google Scholar
• Boll K, Reiche K, Kasack K et al. MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32(3), 277–285 (2013).
   PubMed Web of Science ®Google Scholar
• Hagman Z, Haflidadottir BS, Ceder JA et al. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br. J. Cancer 108(8), 1668–1676 (2013).
   PubMed Web of Science ®Google Scholar
• Fendler A, Stephan C, Yousef GM, Jung K. MicroRNAs as regulators of signal transduction in urological tumors. Clin. Chem. 57(7), 954–968 (2011).
   PubMed Web of Science ®Google Scholar
• Gandellini P, Folini M, Longoni N et al. miR-205 exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res. 69(6), 2287–2295 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu C, Li J, Cheng G et al. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells. Mol. Cell. Biochem. 379(1–2), 69–75 (2013).
   PubMed Web of Science ®Google Scholar
• Ren D, Wang M, Guo W et al. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR145. Int. J. Oncol. 42(4), 1473–1481 (2013).
   PubMed Web of Science ®Google Scholar
• Ishteiwy RA, Ward TM, Dykxhoorn DM, Burnstein KL. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells. PLoS ONE 7(12), e52106; 1–9 (2012).
   PubMed Web of Science ®Google Scholar
• Qu Y, Li WC, Hellem MR et al. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. Int. J. Cancer 133(3), 544–555 (2013).
   PubMed Web of Science ®Google Scholar
• Parray A, Siddique HR, Kuriger JK et al. ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African–American and Caucasian prostate cancer models. Int. J. Cancer 135(11), 2493–2506 (2014).
   PubMed Web of Science ®Google Scholar
• Kizuka Y, Taniguchi N. Enzymes for N-glycan branching and their genetic and nongenetic regulation in cancer. Biomolecules 6(2), 1–21 (2016).
   PubMed Web of Science ®Google Scholar
• Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13(8), 877–883 (2011).
   PubMed Web of Science ®Google Scholar
• Zanconato F, Cordenonsi M, Piccolo S. YAP/TAZ at the roots of cancer. Cancer Cell 29(6), 783–803 (2016).
   PubMed Web of Science ®Google Scholar
• Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain. Proc. Natl Acad. Sci. USA 109(37), E2441–2450 (2012).
   PubMed Web of Science ®Google Scholar
• Seo WI, Park S, Gwak J et al. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP. Biochem. Biophys. Res. Commun. 486(4), 1034–1039 (2017).
   PubMed Web of Science ®Google Scholar
• Varzavand A, Hacker W, Ma D et al. alpha3beta1 integrin suppresses prostate cancer metastasis via regulation of the Hippo pathway. Cancer Res. 76(22), 6577–6587 (2016).
   PubMed Web of Science ®Google Scholar
• Liu N, Mei L, Fan X et al. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway. Cancer Lett. 378(1), 38–50 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang YL, Wang RC, Cheng K, Ring BZ, Su L. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol. Med. 14(1), 90–99 (2017).
   PubMed Web of Science ®Google Scholar
• Peak JC, Jones NP, Hobbs S, Katan M, Eccles SA. Phospholipase C gamma 1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion. Oncogene 27(20), 2823–2832 (2008).
   PubMed Web of Science ®Google Scholar
• Bailey CL, Kelly P, Casey PJ. Activation of Rap1 promotes prostate cancer metastasis. Cancer Res. 69(12), 4962–4968 (2009).
   PubMed Web of Science ®Google Scholar
• Hansen TB, Kjems J, Damgaard CK. Circular RNA and miR-7 in cancer. Cancer Res. 73(18), 5609–5612 (2013).
   PubMed Web of Science ®Google Scholar
• Fu X, Zhang W, Su Y, Lu L, Wang D, Wang H. MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer. Prostate 76(6), 543–551 (2016).
   PubMed Web of Science ®Google Scholar